Current Edition

behavioural therapy

Deep Brain Stimulation Could Address Suicide Risk in Individuals Resistant to Treatment

Pharmaceutical and behavioural therapy treatments have successfully helped many patients manage symptoms of mental health conditions, such as major depressive disorder (MDD), posttraumatic stress disorder …

Continue Reading →
2018

Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache

Eli Lilly and Company (NYSE: LLY) announced today it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migraine and cluster …

Continue Reading →